PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075933
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075933
Rapid Medical Diagnostic Kits Market is estimated to be valued at USD 29.95 Bn in 2026 and is expected to reach USD 57.26 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 29.95 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.70% | 2033 Value Projection: | USD 57.26 Bn |
Rapid diagnostic tests (RDTs) refer to a group of diagnostics categorized by performance characteristics rather than the specific analyte or test platform. Such assays have relatively short performance times, provide results to inform clinical decision making, and enable management at the point-of-care (POC). RDTs are available in a variety of test formats and platforms for various detection targets. RDTs are designed for detecting pathogen-specific antigens or nucleic acid sequences, as well as host antibody responses against certain pathogens.
Increasing research and development activities by the market players to develop novel product for the rapid diagnosis of infectious diseases. Moreover, the increasing prevalence of infectious diseases globally is expected to drive market growth over the forecast period. For instance, according to the data published by the Center for Disease Control and Prevention in 2020, the number of new tuberculosis cases was 8,916, and the number of new Lyme disease cases was 34,945.
Rapid Medical Diagnostic Kits Market Segmentation: